References
- 1
LeRoith D, Novosyadlyy R, Gallagher EJ, Lann D, Vojayakumar A, Yakar S.
Obesity and type 2 diabetes are associated with an increased risk of developing cancer
and a worse prognosis; epidemiological and mechanistic evidence.
Exp Clin Endocrinol Diab.
2008;
- 2
Mziaut H, Trajkovski M, Kersting S. et al .
Synergy of glucose and growth hormone signalling in islet cells through ICA512 and
STAT5.
Nat Cell Biol.
2006;
8
((5))
435-445
- 3
Meisterfeld R, Ehehalt F, Saeger HD, Solimena M.
Pancreatic disorders and diabetes mellitus.
Exp Clin Endocrinol Diab.
2008;
1
1
- 4
Suess C, Solimena M.
Proteomic profiling of ß-cells using a classical approach - two-dimensional gel electrophoresis.
Exp Clin Endocrinol Diab.
2008;
1
1
- 5
Konstantinova I, Nikolova G, Ohara-Imaizumi M. et al .
EphA-Ephrin-A-mediated beta cell communication regulates insulin secretion from pancreatic
islets.
Cell.
2007;
129
((2))
359-370
- 6
Lammert E.
The vascular trigger of type II diabetes mellitus.
Exp Clin Endocrinol Diab.
2008;
- 7
Jabs N, Franklin I, Brenner MB. et al .
Reduced insulin secretion and content in VEGF-A deficient mouse pancreatic islets.
Exp Clin Endocrinol Diab.
2008;
- 8
Bonifacio E, Achenbach P, Pan L, Ziegler AG.
Mucosal insulin vaccination for type 1 diabetes prevention.
Exp Clin Endocrinol Diab.
2008;
- 9
Staeva-Vieira T, Peakman M, von HM.
Translational mini-review series on type 1 diabetes: Immune-based therapeutic approaches
for type 1 diabetes.
Clin Exp Immunol.
2007;
148
((1))
17-31
- 10
Bornstein SR, Erhart-Bornstein M, Wong ML, Licinio J.
Is the worldwide epidemic of obesity a communicable feature of globalization.
Exp Clin Endocrinol Diab.
2008;
- 11
Bergman A, Li J, Selisko T. et al .
The A98V Single Nucleotide Polymorphism (SNP) in Hepatic Nuclear Factor 1 alpha (HNF
1 alpha) is associated with insulin sensitivity and beta-cell Function.
Exp Clin Endocrinol Diab.
2008;
- 12
Bergman A, Li J, Reimann M. et al .
Polymorphism in Perilipin gene (PLIN) are not associated with obesity and weight variation
in people with high risk of type 2 diabetes.
Exp Clin Endocrinol Diab.
2008;
- 13
Stratmann B, Tschope D.
Sweet Heart – contribution of metabolism in the development of heart failure in diabetes
mellitus.
Exp Clin Endocrinol Diab.
2008;
- 14
Papewalis C, Jacobs B, Wuttke M, Schott M.
Cellular therapies in endocrine diseases.
Exp Clin Endocrinol Diab.
2008;
- 15
Hermsen D, Liu C, Domberg J. et al .
Comparison of a solid phase human versus porcine thyrotropin receptor-based immunoassay
for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases.
Exp Clin Endocrinol Diab.
2008;
1
1
- 16
Schinner S, Kempf K, Overmann H. et al .
Association of impaired glucose metabolism in morbid obesity with hypoadiponectinaemia.
Horm Metab Res.
2008;
1
1
- 17
Willenberg HS, Ansurudeen I, Schebesta K. et al .
The endothelium secretes interleukin-6 (IL-6) and induces IL-6 and aldosterone generation
by adrenocortical cells.
Exp Clin Endocrinol Diab.
2008;
- 18
Scherbaum WA, Schrell U, Gluck M, Fahlbusch R, Pfeiffer EF.
Autoantibodies to pituitary corticotropin-producing cells: possible marker for unfavourable
outcome after pituitary microsurgery for Cushing's disease.
Lancet.
1987;
1
((8547))
1394-1398
- 19
Scherbaum WA, Bottazzo GF.
Autoantibodies to vasopressin cells in idiopathic diabetes insipidus: evidence for
an autoimmune variant.
Lancet.
1983;
1
((8330))
897-901
- 20
Richter W, Endl J, Eiermann TH, Brandt M, Kientsch-Engel R, Thivolet C, Jungfer H,
Scherbaum WA.
Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes
mellitus reveal glutamate decarboxylase as the target antigen.
Proc Natl Acad Sci USA.
1992;
15; 89
((18))
8467-8471
- 21
Bornstein SR, Gonzalez-Hernandez JA, Ehrhart-Bornstein M, Adler G, Scherbaum WA.
Intimate contact of chromaffin and cortical cells within the human adrenal gland forms
the cellular basis for important intraadrenal interactions.
J Clin Endocrinol Metab.
1994;
78
((1))
225-232
- 22
Schott M, Scherbaum WA, Morgenthaler H.
Thyrotropin receptor autoantibodies in Graves’ disease.
Trends Endocrinol Metab.
2005;
16
((5))
243-248
- 23
Schott M, Feldkamp J, Schattenberg D, Seissler J, Scherbaum WA.
Dendritic cell immunotherapy in disseminated parathyroid carcinoma.
Lancet.
1999;
353
((9159))
1188-1189
Correspondence
Priv .Doz. Dr. M. Schott
Universitätsklinikum Duesseldorf
Moorenstr. 5
40225 Duesseldorf
Phone: +49/211/811 78 10
Fax: +49/211/811 78 60
Email: matthias.schott@med.uni-duesseldorf.de
